Neural mechanisms of tardive dyskinesia.

T. Lidsky,J. S. Schneider

DOI: https://doi.org/10.1016/0306-9877(81)90053-0

IF: 4.7

1981-09-01

Medical Hypotheses

Abstract:

What problem does this paper attempt to address?

Bilateral Morganella Morganii Keratitis in A Patient with Facial Topical Corticosteroid-Induced Rosacea-Like Dermatitis: A Case Report

Bei Zhang,Fei Pan,Kejian Zhu

DOI: https://doi.org/10.1186/s12886-017-0504-5

IF: 2.086

2017-01-01

BMC Ophthalmology

Abstract:Background: Bilateral keratitis rarely occurs in individuals without predisposing factors. Here we describe the clinical course of a patient who developed a bilateral keratitis caused by Morganella. morganii which might be associated with long term using of topical corticosteroids-containing preparations on the face.Case presentation: A 52-year-old female patient presented with marked bilateral corneal infiltration and hypopyon without any usual predisposing factors for bilateral infectious keratitis. There was diffuse erythema with itching on face before the onset of eye discomforts. Microbiological culture of materials from both corneas revealed significant growth of Morganella morganii. Topical corticosteroid-induced rosacea-like dermatitis was diagnosed by dermatologist because of the characteristic eruptions and long history of using the corticosteroids-containing cosmetic creams on her face. The corneal ulcers responded well to levofloxacin eye drops and ofloxacin ointment and healed with opacity and neovascularization.Conclusion: This case illustrates that bilateral bacterial corneal infection can develop in patients with long term using of topical corticosteroids-containing preparations on the face. To our knowledge, this is the first case of bilateral keratitis caused by Morganella morganii.
Early exercise testing after myocardial infarction.

R. Debusk

Abstract:
Ocular manifestations of rosacea: A clinical review

Shokufeh Tavassoli,Nathan Wong,Elsie Chan

DOI: https://doi.org/10.1111/ceo.13900

2021-02-03

Clinical and Experimental Ophthalmology

Abstract:Ocular rosacea is a chronic inflammatory condition that can occur in the absence of cutaneous features. The most common ocular features are chronic blepharoconjunctivitis with eyelid margin inflammation, and meibomian gland dysfunction. Corneal complications include corneal vascularisation, ulceration, scarring and, rarely, perforation. Diagnosis is largely based on clinical signs, although it is often delayed in the absence of cutaneous changes, particularly in children. It can also be associated with systemic disorders such as cardiovascular disease. Management ranges from local therapy to systemic treatment, depending on the severity of the disease. In this review, we describe the epidemiology, pathophysiology, clinical features and treatment of rosacea and ocular rosacea.

ophthalmology
Ocular rosacea without facial erythema involvement manifesting as bilateral multiple recurrent chalazions: A case report

Xue-Mei Han,Yi-Mai Zhou,Lu-Sha Cen

DOI: https://doi.org/10.12998/wjcc.v12.i17.3253

2024-06-16

World Journal of Clinical Cases

Abstract:BACKGROUND In addition to the non-specific symptomatology of ocular rosacea, currently, there are no reliable diagnostic tests for the disease, which may lead to its misdiagnosis. Here, we report a case of ocular rosacea presenting with multiple recurrent chalazion on both eyelids. CASE SUMMARY A 63-year-old female patient presented with multiple chalazion and dry eyes in both eyes, with no facial erythema. Initial management done were application of steroid eye ointment on both eyelids, hot compresses, and eyelid margin cleaning; noting that there was no relief of symptoms. Surgical excision of the chalazion was done on both eyes, however, bilateral recurrence occurred post-operatively. The pathological studies showed infiltration of a small amount of fibrous tissue with many chronic inflammatory cells. Immunohistochemistry studies were positive for LL-37. Resolution of the chalazion occurred after oral administration of doxycycline and azithromycin. CONCLUSION Our findings show that ophthalmologists should recognize the ocular manifestations of skin diseases.

medicine, general & internal
Nutrition services for pregnant adolescents within a public high school.

I. Alton

DOI: https://doi.org/10.1016/s0002-8223(21)05640-6

Journal of the American Dietetic Association

Abstract:
Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconylphorbol-13-acetate: a molecular analysis.

M. Tzukerman,Xiao‐kun Zhang,Magnus Pfahl

DOI: https://doi.org/10.1210/MEND-5-12-1983

1991-12-01

Molecular Endocrinology

Abstract:Cell proliferation and phenotype of cells from female reproductive tissues are regulated by estrogens. It is therefore important to understand how estrogen action can be modulated. It recently has been reported that certain nuclear receptors can antagonize the tumor promoter 12-O-tetradeconylphorbol-13-acetate (TPA) by direct interaction with the transcription factor AP-1, and that the AP-1 constituents cJun and cFos can inhibit receptor activity. This mutual antagonism appears to be based on direct protein-protein interaction. In the human breast cancer cell line MCF-7, TPA leads to growth arrest and altered cell morphology. We have investigated here whether in MCF-7 cells and other cell lines AP-1 and estrogen receptors (ERs) can inhibit each other's activity. We find that TPA or the AP-1 components cJun and cFos can inhibit estradiol-dependent estrogen receptor activity in most cell lines investigated. In addition, ER mRNA is rapidly down-regulated in MCF-7 cells. Gel retardation experiments show that ER DNA binding is inhibited in vitro by cJun protein, while ER also can inhibit cJun DNA binding. However, in vivo we do not observe inhibition of AP-1 activity by ER in the cell lines investigated here. On the contrary, we observed an enhancing effect at low ER concentrations on AP-1. Together our data suggest a new regulatory pathway by which ER activity can be modulated by AP-1. Several mechanisms including ER-AP-1 protein interaction appear to be involved.
[Significance of cardiac blood pool scintigraphy using intravenous injection of isosorbide dinitrate for the evaluation of viability of ischemic myocardium].

Y. Kubota,H. Sugihara,T. Nakagawa,T. Katahira,S. Inagaki,K. Furukawa,J. Asayama,H. Adachi,H. Katsume,M. Nakagawa

1989-03-01

Abstract:
Skincare in Rosacea from the Cosmetologist's Perspective: A Narrative Review

Danuta Nowicka,Karolina Chilicka,Iwona Dzieńdziora-Urbińska,Renata Szyguła

DOI: https://doi.org/10.3390/jcm12010115

2022-12-23

Abstract:Rosacea is a common skin disease that affects about 5% of the general population. Its symptoms include telangiectasia, persistent erythema, burning/stinging sensation, dry skin sensation, and pruritus. It is characterized by a chronic course with frequent exacerbation. It often coexists with anxiety and depression, reducing the quality of life of affected patients. The etiopathogenesis of rosacea is complex and not fully elucidated; hence, there is no causative effective treatment. In this review, we highlight the role of a cosmetologist in the treatment of rosacea and the maintenance of remission. As part of medical treatment, patients are advised to introduce lifestyle changes and use proper skin care; a cosmetologist can help educate patients affected with rosacea, create effective home care programs for skin care, and support them with treatments in beauty salons. Proper skin care is essential, including the use of dermocosmetics, cleansing of the skin, and frequent visits to beauty salons for tailored apparatus procedures. A cosmetologist is more accessible to patients and can help implement healthy daily habits, including skin care and eating habits, as well as support and mediate good communication between the patient and the patient's treating physician, thereby improving compliance and ensuring long-term satisfactory outcomes.
Ocular Manifestations in Seborrheic Dermatitis Epidemiology, Clinical Features, and Management: A Comprehensive Review

Rasha M Alofi,Lujain S Alrohaily,Nada N Alharthi,May M Almouteri

DOI: https://doi.org/10.7759/cureus.70335

2024-09-27

Cureus

Abstract:Seborrheic dermatitis (SD) often leads to ocular manifestations (OM) that are frequently overlooked. This study comprehensively explains the genesis of these ocular issues, which involves a combination of Malassezia overgrowth, changes in sebum production, and inflammatory responses in the body. The periocular region is rich in sebaceous glands, allowing Malassezia to thrive, which can lead to an inflammatory reaction that spreads to the eye surface, causing disorders such as blepharitis, conjunctivitis, keratitis, and ocular surface diseases. Although epidemiological data are limited, it is well established that ocular involvement occurs in approximately 10%-40% of individuals with SD. Early detection and treatment are crucial to prevent potential vision-threatening complications. A comprehensive diagnostic approach is necessary, including clinical examination, slit-lamp biomicroscopy, tear film analysis, and corneal imaging. Managing these conditions requires a multidisciplinary strategy involving collaboration between dermatologists and ophthalmologists. The treatment should involve topical and systemic medications to address the skin and ocular components. Patient education is critical for improving adherence to therapy, self-management, and the early identification of problems. In the future, it will be essential to investigate the intricate interactions between Malassezia species and host immunological processes. This collective effort will involve creating new biomarkers and diagnostic tools, investigating targeted immunomodulatory drugs and novel lipid-based medicines as potential treatments, and conducting large-scale longitudinal studies to understand the epidemiological patterns and prognostic variables better. By raising awareness, encouraging collaboration across disciplines, and advancing research, healthcare practitioners can significantly improve patients' quality of life with SD and OM.
Prevalence of ocular manifestations in cutaneous rosacea: Protocol for a systematic review and meta-analysis

Kristina Nazzicone,Ryan H. Kirkpatrick,Aleksandar Biorac,Anneke R. Froentjes,Sonja Molin,Sarah Simpson

DOI: https://doi.org/10.1101/2024.01.31.24301198

2024-02-01

Abstract:Introduction: Rosacea is a chronic inflammatory skin condition with concomitant ocular manifestations and neurogenic symptoms. Ocular rosacea poses a particular diagnostic challenge as its signs and symptoms often overlap with other ocular pathologies. Cutaneous and ocular rosacea present together in approximately 21-50% of patients, yet a solid understanding of comorbid ocular and cutaneous symptoms is lacking. Therefore, the present paper outlines a protocol for a systematic review and meta-analysis to describe and quantify the prevalence of ocular rosacea in cutaneous rosacea and each of its subtypes. Methods: This study will follow Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and be conducted using the systematic review software, Covidence. To determine inclusion, screening will occur at two levels (title and abstract-only followed by full-text) and will be completed separately by two authors. Primary research studies on ocular rosacea in adult cutaneous rosacea published in all languages and geographic regions until November 2023 will be reviewed for inclusion. Data pertaining to overall prevalence of ocular rosacea across and within cutaneous rosacea subtypes, mean age, sex, gender, ethnicity, socioeconomic status, time to diagnosis, time to treatment, and prevalence of comorbid conditions will be extracted. For each included study, the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) framework will be applied to assess study quality. Conclusion: To the authors’ knowledge, this will be the first systematic review and meta-analysis comparing the prevalence of ocular rosacea in the various cutaneous subtypes in an adult population. By addressing this knowledge gap, this study aims to provide clear and easily interpretable data to aid in the early diagnosis and treatment of ocular rosacea. This study is registered in the International Prospective Register of Systematic Reviews (PROSPERO ID# CRD42023475026).

Dermatology
Follow up study: The influence of rTMS with high and low frequency stimulation on motor and executive function in Parkinson’s disease

J. Málly,N. Geisz,E. Dinya

DOI: https://doi.org/10.1016/j.brainresbull.2017.10.002

IF: 3.715

2017-10-01

Brain Research Bulletin

Abstract:
Rosacea management: A comprehensive review

Anuj Sharma,George Kroumpouzos,Martin Kassir,Hassan Galadari,Andy Goren,Stephan Grabbe,Mohamad Goldust

DOI: https://doi.org/10.1111/jocd.14816

Abstract:Rosacea is a chronic cutaneous disorder affecting primarily the face, characterized by erythema, transient or persistent, telangiectasia, and inflammatory lesions including papulo-pustules and swelling. The essential component of the disease is the persistent erythema of facial skin. Episodes of flushing (acute-subacute intermittent vasodilation) are common. Swelling and erythema of the nose along with dilatation of the pilosebaceous poral orifices, known as rhinophyma, can be noted in chronic cases. Rosacea affects up to 10% of the world population and is especially noted in fair-skinned individuals aged 35-50. Women are affected more often than men. Several treatment modalities including topical medications, systemic drugs, lasers, and light-based therapies have been used for the management of rosacea with variable results. Topical medications such as azelaic acid, metronidazole, and sulfacetamide/sulfur, oral antibiotics such as tetracyclines, and oral retinoids alone or, most commonly, in combination form the mainstay of treatment. Light therapies such as intense pulsed light and pulsed dye laser are best used for the erythemato-telangiectatic type. Topical brimonidine, oxymetazoline, ivermectin, tacrolimus, pimecrolimus, low-dose modified-release tetracyclines and botulinum toxin are the new additions to the therapeutic armamentarium. This article provides a comprehensive review of the various therapies used for rosacea.
Rosacea: Common Questions and Answers

Winfred Frazier,Raquel K Zemtsov,Yufei Ge

Abstract:Rosacea is a chronic inflammatory skin disease of the central face, affecting 5% of the population. The exact etiology is unknown. A diagnosis is made based on the updated 2017 National Rosacea Society Expert Committee guidelines, including fixed erythema, phymatous changes of skin thickening due to sebaceous gland hyperplasia and fibrosis, papules, pustules, telangiectasia, and flushing. Delays in an accurate diagnosis and treatment may occur in skin of color due to difficulty visualizing erythema and telangiectasia. The daily use of sunscreen, moisturizers, and mild skin cleansers and avoidance of triggers are essential aspects of maintenance treatment. Effective topical treatment options include alpha-adrenergic receptor agonists for flushing and ivermectin, metronidazole, and azelaic acid for papules and pustules. Systemic treatments include nonselective beta blockers for flushing, low-dose doxycycline, and isotretinoin for papules and pustules. Rosacea can significantly affect a patient's emotional health and quality of life. A referral for care is recommended for fixed phymatous changes and ocular rosacea. (Am Fam Physician. 2024;109(6):533-542.
Ocular surface disorders: office procedures for the allergist/clinical immunologist

Matthew Ryan Norris,Constance Katelaris,Nelson Rosario,Luis Delgado,Andrea Leonardi,Leonard Bielory

DOI: https://doi.org/10.1097/ACI.0000000000001022

2024-08-13

Abstract:Purpose of review: Ocular surface disorders (OSDs) are a prevalent and often debilitating condition encountered in clinical practice, particularly by allergists and clinical immunologists. Recent findings: A comprehensive guide to office procedures for evaluating and managing OSDs, with a specific focus on ocular allergies, would assist in the evaluation process that begins with an initial patient assessment utilizing standardized forms to systematically gather detailed medical history, symptomatology, and environmental exposure data. This structured approach ensures a thorough understanding of the patient's condition and facilitates targeted interventions. In addition to allergy testing, the assessment of the tear film is essential for a comprehensive evaluation of OSDs. The Schirmer test is employed to quantify tear production, providing objective data on tear film adequacy and guiding interventions for tear film deficiencies. Summary: This multifaceted diagnostic approach ensures that all contributing factors to OSDs are identified and appropriately managed. By integrating these office procedures, allergists and clinical immunologists can enhance their diagnostic accuracy and therapeutic efficacy, ultimately improving patient outcomes. This manuscript provides a practical resource, outlining some of the methodologies and clinical applications of each procedure, and highlighting their role in the holistic management of OSDs in allergic patients.
A Review of the Challenges and Nuances in Treating Rosacea in Asian Skin Types Using Cleansers and Moisturizers as Adjuncts

Kanokvalai Kulthanan,Anneke Andriessen,Xian Jiang,Chih-Hung Lee,Cheng-Feng Zhang

DOI: https://doi.org/10.36849/JDD.7021

2023-01-01

Abstract:Background: Rosacea is primarily an inflammatory disease of facial skin associated with impaired skin barrier function. While it is commonly thought of as a Caucasian person's disease, it is likely underdiagnosed in people of color, including Asians, leading to missed and delayed diagnoses and increased morbidity. The purpose of this review is to highlight literature on rosacea in Asian people and the role of non-prescription skincare in managing rosacea. Methods: Four dermatologists (the panel) completed pre-meeting surveys and participated in a web meeting to discuss the role of skin care in treating rosacea in the Asia Pacific (APAC) region. The survey results were summarized, then presented during the virtual meeting. These survey results and relevant papers identified through a literature review were then discussed. This review shows the fruit of these discussions, as well as the advisors' expert opinions and experiences. Results: The panel crafted 5 consensus statements regarding the role of skin care in the treatment of rosacea in the APAC region. The most common forms of rosacea seen by the advisors are mostly erythematous and papulopustular. Among the panel, doxycycline is the most popular treatment for papulopustular rosacea. The panel prioritize gentleness when choosing skincare products for patients with rosacea. Conclusions: In Asian patients with rosacea, adjunctive skincare is an important part of treatment, maintenance, and prescription treatment. Given the highly sensitive skin of certain Asian patients with rosacea, avoiding potentially irritating substances is crucial. J Drugs Dermatol. 2023;22(1):45-53. doi:10.36849/JDD.7021.
Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy

Raul E. Ruiz-Lozano,Nadim S. Azar,Hazem M. Mousa,Manuel E. Quiroga-Garza,Seitaro Komai,Lorena Wheelock-Gutierrez,Cristian Cartes,Victor L. Perez

DOI: https://doi.org/10.3389/ftox.2023.1067942

2023-07-21

Frontiers in Toxicology

Abstract:Ocular surface disease (OSD), a disorder affecting the lacrimal and meibomian glands and the corneal and conjunctival epithelium, is a well-known complication of topical glaucoma therapy. OSD can present as a new or pre-existing condition that virtually any anti-glaucoma formulation can exacerbate. As such, both glaucoma and OSD frequently coexist. Typical OSD symptoms include ocular discomfort, redness, burning, and dryness, whereas signs include periorbital and eyelid skin pigmentation, conjunctival scarring, and superficial punctate keratitis. Pressure-lowering eyedrops can cause toxic, allergic, and inflammatory reactions on the ocular surface. The latter can result from either preservatives or direct toxicity from the active molecule. Although usually mild, OSD can cause significant symptoms that lead to poor quality of life, decreased compliance to therapy, glaucoma progression, and worse visual outcomes. Given the chronic nature of glaucoma, lack of curative therapy, and subsequent lifelong treatment, addressing OSD is necessary. This manuscript aims to provide an up-to-date overview of OSD’s signs, symptoms, and pathogenic mechanisms from glaucoma therapy toxicity.
An unusual Bilateral cicatrizing conjunctivitis in severe ocular rosacea

Hala El B,

DOI: https://doi.org/10.55920/2771-019x/1396

2023-03-16

Journal of Clinical and Medical Images, Case Reports

Abstract:Rosacea is a chronic progressive disease of unknown cause that affects the eyes and facial skin. Ocular rosacea is often missed when ophthalmologists do not adequately examine a patient's face during eye exams. If treatment is delayed due to undiagnosed rosacea, serious eye complications and blindness can occur. We present a case of 35-year-old female, followed up for rosacea and severe depressive disorder, presented with bilateral, symmetrical blinding cicatricial conjunctivitis after neglected ocular self-injury.
Developmental expression and gene/enzyme identifications in the alpha esterase gene cluster of Drosophila melanogaster

P. M. Campbell,G. de Q. Robin,L. Court,S. J. Dorrian,R. Russell,J. Oakeshott

DOI: https://doi.org/10.1046/j.1365-2583.2003.00430.x

2003-10-01

Abstract:Here we show how the 10 genes of the alpha esterase cluster of Drosophila melanogaster have diverged substantially in their expression profiles. Together with previously described sequence divergence this suggests substantial functional diversification. By peptide mass fingerprinting and in vitro gene expression we have also shown that two of the genes encode the isozymes EST9 (formerly ESTC) and EST23. EST9 is the major ‘alpha staining’ esterase in zymograms of gut tissues in feeding stages while orthologues of EST23 confer resistance to organophosphorus insecticides in other higher Diptera. The results for EST9 and EST23 concur with previous suggestions that the products of the alpha esterase cluster function in digestion and detoxification of xenobiotic esters. However, many of the other genes in the cluster show developmental or tissue‐specific expression that seems inconsistent with such roles. Furthermore, there is generally poor correspondence between the mRNA expression patterns of the remaining eight genes and isozymes previously characterized by standard techniques of electrophoresis and staining, suggesting that the alpha cluster might only account for a small minority of the esterase isozyme profile.
Rosacea in East Asian populations: Clinical manifestations and pathophysiological perspectives for accurate diagnosis

Yoshimasa Nobeyama

DOI: https://doi.org/10.1111/1346-8138.17411

Abstract:Rosacea is a chronic inflammatory disorder primarily affecting the facial skin, prominently involving the cheeks, nose, chin, forehead, and periorbital area. Cutaneous manifestations encompass persistent facial erythema, phymas, papules, pustules, telangiectasia, and flushing. The pathogenesis of rosacea is associated with various exacerbating or triggering factors, including microbial infestation, temperature fluctuations, sunlight exposure, physical exertion, emotional stress, consumption of hot beverages and spicy foods, and exposure to airborne pollen. These environmental factors interact with genetic predispositions in the development of rosacea. The roles of the lipophilic microbiome, ultraviolet radiation, nociceptive responses, and vascular alterations have been proposed as significant factors in the pathogenesis. These insights contribute to understanding the anatomical specificity of facial involvement and the progressive nature of rosacea. East Asian skin, predominantly classified as Fitzpatrick skin phototypes III to IV, is characterized by relatively diminished skin barrier function and increased sensitivity to irritants. Airborne pollen exposure may particularly act as a trigger in East Asian individuals, possibly mediated through toll-like receptors. The lack of specificity in objective clinical and histopathological findings leads to diagnostic challenges for individuals with colored skin, including East Asians, particularly when erythema is the sole objective manifestation. An alternative diagnostic scheme may thus be necessary. A diagnostic approach emphasizing vascular manifestations and nociceptive symptoms potentially holds promise for individuals with darker skin tones. More research focusing on potential variations in skin physiology across different racial groups is essential to establish more effective diagnostic schemes applicable to both dark and light skin colors.
Comprehensive ophthalmological evaluation in atopic dermatitis

Anais Valeille,Coralie Ouilhon,Fabien Subtil,Florence Hacard,Coline Jaulent,Fréderic Bérard,Jean-François Nicolas,Jean-Luc Fauquert,Audrey Nosbaum

DOI: https://doi.org/10.1159/000536233

2024-02-14

Dermatology

Abstract:BACKGROUND: Atopic dermatitis (AD), a chronic Type 2 inflammatory skin disease, is frequently associated with ocular surface diseases (OSD) which may appear or worsen under anti-Type 2-targeted treatments. However, the exact prevalence of OSD and the ophthalmology referral criteria remain ill-defined in AD patients before initiating such biotherapies. OBJECTIVE: We aimed to characterize the prevalence, the nature and the factors related to OSD development in AD that may justify an ophthalmological management. METHODS: A total of 98 consecutive AD inpatients without biological treatment were retrospectively included. These were systematically evaluated by an ophthalmologist during their dermatological care. Clinical and laboratory data were analyzed to characterize OSD and their risk factors. RESULTS: OSD were found in 83/98 AD patients (85%); mainly dry eye syndrome (64%, 63/98), allergic conjunctivitis (42%, 41/98), posterior (33%, 32/98), and anterior blepharitis (27%, 26/98). In AD patients without ocular symptoms, OSD were also frequently found (63%, 12/19) and were mostly mild. Risk factors for OSD were history of allergic rhinitis, allergic sensitization, head and neck AD, ocular symptoms (foreign body sensation in the eye, burning, itching, photophobia), and total IgE level >3000kU/L. CONCLUSION: The prevalence of OSD was high, even in asymptomatic patients. The risk factors identified may indicate the need for ophthalmological examination for therapeutic management, especially when biological agents targeting Type 2 inflammation are considered.

dermatology

Neural mechanisms of tardive dyskinesia.

Bilateral Morganella Morganii Keratitis in A Patient with Facial Topical Corticosteroid-Induced Rosacea-Like Dermatitis: A Case Report

Early exercise testing after myocardial infarction.

Ocular manifestations of rosacea: A clinical review

Ocular rosacea without facial erythema involvement manifesting as bilateral multiple recurrent chalazions: A case report

Nutrition services for pregnant adolescents within a public high school.

Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconylphorbol-13-acetate: a molecular analysis.

[Significance of cardiac blood pool scintigraphy using intravenous injection of isosorbide dinitrate for the evaluation of viability of ischemic myocardium].

Skincare in Rosacea from the Cosmetologist's Perspective: A Narrative Review

Ocular Manifestations in Seborrheic Dermatitis Epidemiology, Clinical Features, and Management: A Comprehensive Review

Prevalence of ocular manifestations in cutaneous rosacea: Protocol for a systematic review and meta-analysis

Follow up study: The influence of rTMS with high and low frequency stimulation on motor and executive function in Parkinson’s disease

Rosacea management: A comprehensive review

Rosacea: Common Questions and Answers

Ocular surface disorders: office procedures for the allergist/clinical immunologist

A Review of the Challenges and Nuances in Treating Rosacea in Asian Skin Types Using Cleansers and Moisturizers as Adjuncts

Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy

An unusual Bilateral cicatrizing conjunctivitis in severe ocular rosacea

Developmental expression and gene/enzyme identifications in the alpha esterase gene cluster of Drosophila melanogaster

Rosacea in East Asian populations: Clinical manifestations and pathophysiological perspectives for accurate diagnosis

Comprehensive ophthalmological evaluation in atopic dermatitis